Findings showed 40% of patients treated with dupilumab achieved an IGA score of 0 (clear) or 1 (almost clear) on the hands and feet at week 16, compared with 17% of those who received placebo. The ...

Atopic dermatitis is a chronic inflammatory skin disease that causes extreme dryness, itchy rashes, scaly patches, and blisters that can ooze, crust, and flake. It affects people of all ages, all over ...

Cleaning products can often trigger symptoms of atopic dermatitis. Find out what experts recommend to help you avoid eczema ...

Atopic dermatitis, the most common form of eczema, affects millions of Americans with its hallmark symptoms of dry, itchy, and inflamed skin. While this chronic condition can impact individuals across ...

Please provide your email address to receive an email when new articles are posted on . Adults with atopic dermatitis with hand involvement saw skin improvements as early as 2 weeks with tralokinumab.

If you’re a person of color, finding the right treatment for atopic dermatitis, a common form of eczema, can be challenging. Even though the disease is more prevalent in Black Americans than white ...

To calm aggravated skin due to atopic dermatitis and other forms of eczema, follow a personalized regimen every day, not just ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

For many people with atopic dermatitis (AD) — sometimes called severe or uncontrolled eczema — avoiding environmental triggers can reduce flares and keep symptoms under control. Simple swap-outs of ...

TRexBio to Present Late-Breaking Data at SID 2026 Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis ...

Atopic dermatitis is the most common type of eczema. It’s a chronic condition that causes itchy skin and other skin symptoms. Although most people with this condition have symptoms in childhood, it ...

In this video, Lawrence F. Eichenfield, MD, discusses topical 0.05% roflumilast for infants and young children, from his ...